Drug notes:
Also Clin2 Alzheimer's; AL002 Clin2 Alzheimer's (partner: AbbVie)
About:
Alector is developing therapies for the treatment of neurodegenerative diseases. Despite the rise in the number of patients suffering with brain disorders there is still a lack of effective therapeutics. Immune cells in the brain are important for brain health. By combining antibody technology, human genetics and the latest insights in neuroscience, Alector is building a pipeline of therapeutics to harness the body’s own immune system to heal itself. This immuno-neurology strategy is analogous to current immuno-oncology approaches to activate and recruit the adaptive immune response. Through partnering with other companies such as GSK, Alector currently has many therapeutics in Phase 1-3 clinical trials for dementia and Alzheimer’s disease.
Jobs:
HEOR Director United States|28 days ago
Senior Vice President, Research South San Francisco, CA|62 days ago
Director, Vendor Quality Management ~ GxP South San Francisco, CA|67 days ago
Senior Director, Quality Operations South San Francisco, CA|72 days ago